MDXG FY 2025 Earnings — MiMedx Group, Inc. Revenue & Financial Results | Market Cap Arena

MDXGMiMedx Group, Inc.

$684M

FY 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$419M+20.0% YoY

Gross Profit

$346M82.6% margin

Operating Income

$64M15.3% margin

Net Income

$49M11.6% margin

EPS (Diluted)

$0.32

Cash Flow

Operating Cash Flow

$74M

Free Cash Flow

$73M

Stock-Based Comp.

$16M

Balance Sheet

Total Assets

$343M

Total Liabilities

$86M

Stockholders' Equity

$257M

Cash & Equivalents

$166M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$419M	$349M	+20.0%
Gross Profit	$346M	$289M	+19.7%
Operating Income	$64M	$59M	+8.5%
Net Income	$49M	$42M	+14.5%